Clinical Trial Update: VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing efficacy and safety of VEGF Trap-Eye (aflibercept) in Chinese patients with wet age-related macular degeneration; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• VEGF Trap-Eye (aflibercept)

Snippet

Sponsor: Bayer | Conditions: Macular Degeneration | Phase 3 | Status: COMPLETED | Results posted: 2015-03-13